Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases

Clinical Colorectal Cancer

Volumn 11, Issue 3, 2012, Pages 195-199

  Martin, Ludmila Katherine ^a   Cucci, Anthony ^a   Wei, Lai ^a   Rose, Jeffrey ^a   Blazer, Marlo ^a   Schmidt, Carl ^a   Khabiri, Hooman ^a   Bloomston, Mark ^a   Bekaii Saab, Tanios ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Hepatic; Locoregional; Radioembolization; Y 90

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; PROTON PUMP INHIBITOR; YTTRIUM 90;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER METASTASIS; MALE; MEDICAL INFORMATION; METASTATIC COLORECTAL CANCER; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; STOMACH ULCER; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

EID: 84865448894     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.12.002     Document Type: Article

References (29)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics 2010 CA Cancer J Clin 60 2010 277 300
2. Y. Fong, N. Kemeny, P. Paty Treatment of colorectal cancer: hepatic metastasis Semin Surg Oncol 12 1996 219 252
3. D.M. Nagorney, J.F. Gigot Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection Surg Oncol Clinic N Am 5 1996 283 300
4. V.P. Khatri, N.J. Petrelli, J. Belghiti Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23 2005 8490 8499
5. J.S. Tomlinson, W.R. Jarnagin, R.P. DeMatteo Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 205 216
6. T.C. Chua, L. Bester, A. Saxena Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastasis J Cancer Res Clin Oncol 137 2011 865 873
7. N.H. Nicolay, D.P. Berry, R.A. Sharma Liver metastases from colorectal cancer: radioembolization with systemic therapy Nat Rev Clin Oncol 6 2009 687 697
8. E.A. Eisenhauer, P. Therasse, P. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
9. B.J. Giantonio, P.J. Catalano, N.J. Meropol Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 J Clin Oncol 25 2007 1539 1544
10. B. Nordlinger, E. Van Cutsem, P. Rougier Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group Eur J Cancer 43 2007 2037 2045
11. L.B. Saltz, J.V. Cox, C. Blanke Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer Irinotecan Study Group N Engl J Med 343 2000 905 914
12. R.M. Goldberg, D.J. Sargent, R.F. Morton A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 2004 23 30
13. A. de Gramont, M. Figer, M. Homerin Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
14. C. Fuchs, J. Marshall, E. Mitchell Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C study J Clin Oncol 25 2007 4779 4786
15. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 23 2003 2335 2342
16. B.J. Giantonio, P.J. Catalano, N.J. Meropol Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group study E3200 J Clin Oncol 12 2007 1539 1544
17. C.S. Fuchs, J. Marshall, J. Barrueco Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study [letter] J Clin Oncol 26 2008 689 690 [Comment on J Clin Oncol 2007; 25:4779-86]
18. J.Y. Douillard, S. Siena, J. Cassidy Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study J Clin Oncol 28 2010 4697 4705
19. E. Van Cutsem, C.H. Cohne, E. Hitre Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer N Engl J Med 360 2009 1408 1417
20. C. Bokemeyer, I. Bondarenko, A. Makhson Fluorouracil, leucovorin and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 2009 663 671
21. M. Peeters, T.J. Price, A. Cervantes Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer J Clin Oncol 28 2010 4706 4713
22. D. Cunningham, Y. Humblet, S. Siena Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 2004 337 345
23. M.A. Vente, M. Wondergem, I. van der Tweel Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis Eur Radiol 19 2009 951 959
24. B. Atassi, A. Bangash, A. Bahrani Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay Radiographics 28 2008 81 99
25. P. Therasse, S.G. Arbuck, E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
26. A. Raiz, F.H. Miller, L.M. Kulik Imaging responses in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma JAMA 303 2010 1062 1069
27. Y. Sato, H. Watanabe, M. Sone Inter- and intra-criteria reproducibility of RECIST ver 1.1 and modified EASL (European Association for the Study of Liver) tumor response criteria to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): from the dataset JIVROSG (Japan Interventional Radiology in Oncology Group) 0401 J Clin Oncol 27 suppl 2009 e15501
28. M.F. Mulcahy, R.J. Lewandowski, S. Ibrahim Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres Cancer 115 2009 1849 1858
29. C. Tournigand, T. Andre, E. Achille FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 2004 229 237